M. Wetzler et al., EXPRESSION AND FUNCTION OF THE MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR-RECEPTOR IN ACUTE MYELOID-LEUKEMIA BLASTS, Leukemia & lymphoma, 30(5-6), 1998, pp. 415
The receptor for megakaryocyte growth and development factor (MGDF), a
lso known as thrombopoietin, has recently been cloned. MGDF stimulates
platelet production and maturation both in vitro and in vivo. MGDF ma
y thus have a role in attenuating the thrombocytopenia associated with
acute myeloid leukemia (AML) and its therapy. However, there is conce
rn that MGDF might induce AML blast proliferation and thereby increase
the risk of treatment failure. To address this concern, we studied th
e expression of c-mpl mRNA and c-Mpl protein by blasts from AML patien
ts. In addition we examined the in vitro effect of MGDF as well as the
combined effect of MGDF and granulocyte colony-stimulating factor (G-
CSF) or stem cell factor (SCF) on leukemic blast proliferation, recrui
tment into S-phase, induction of programmed cell death and activation
of signal transducers and activators of transcription (STAT) proteins.
Our results demonstrate that blasts from a substantial proportion of
cases of AML express the receptor at either the mRNA or protein level.
Moreover, the function of the MGDF receptor was demonstrated by activ
ation of STAT proteins following exposure to MGDF. Nevertheless, blast
proliferation in response to MGDF was rare, and the proliferative eff
ect of MGDF was less than that of G-CSF or SCF. Furthermore, MGDF did
not prevent programmed cell death induced by cytarabine. Finally, ther
e appeared to be no correlation between receptor expression by AML bla
sts and functional response to MGDF. Based on these data, it would app
ear that clinical trials of MGDF may be undertaken safely in patients
with AML.